Literature DB >> 27107997

Positive correlation of serum HDL cholesterol with blood mercury concentration in metabolic syndrome Korean men (analysis of KNANES 2008-2010, 2013).

S J Park1, K J Yeum2, B Choi3, Y S Kim4, N S Joo5.   

Abstract

PURPOSE: High-density lipoprotein cholesterol (HDLC) is anti-inflammatory in the basal state and pro-inflammatory during the acute-phase response. Blood mercury also has an inflammatory property. Therefore, the aim of this study was to investigate the relationship between serum HDLC and blood mercury concentration in relation with metabolic syndrome (MS).
METHODS: The data of 7616 subjects (3713 men and 3903 women), over 20 years of age, from 2008 to 2013, Korea National Health and Nutrition Examination Survey were selected for cross-sectional analyses. Correlation and regression of serum HDLC and blood mercury were initially done. We compared serum HDLC concentration according to blood mercury quartile after adjustment for relevant variables in subjects with MS.
RESULTS: Mean blood mercury concentrations is 5.6 and 3.9 μg/dL in men and women, respectively. Blood mercury concentration in MS subjects was positively correlated with serum HDLC concentration, especially in men. In addition, HDLC concentration was significantly higher according to the higher blood mercury quartile.
CONCLUSION: Serum HDLC was positively associated with blood mercury concentration in MS Korean men. Therefore, elevated blood mercury may be a factor to increase serum HDLC concentration in MS men.

Entities:  

Keywords:  HDL cholesterol; Mercury; Metabolic syndrome

Mesh:

Substances:

Year:  2016        PMID: 27107997     DOI: 10.1007/s40618-016-0459-z

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  42 in total

1.  Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland.

Authors:  J T Salonen; K Seppänen; T A Lakka; R Salonen; G A Kaplan
Journal:  Atherosclerosis       Date:  2000-02       Impact factor: 5.162

2.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

3.  Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes.

Authors:  N Hyka; J M Dayer; C Modoux; T Kohno; C K Edwards; P Roux-Lombard; D Burger
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

4.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

5.  Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

Authors:  S Matthijs Boekholdt; Benoit J Arsenault; Samia Mora; Terje R Pedersen; John C LaRosa; Paul J Nestel; R John Simes; Paul Durrington; Graham A Hitman; K M A Welch; David A DeMicco; Aeilko H Zwinderman; Michael B Clearfield; John R Downs; Andrew M Tonkin; Helen M Colhoun; Antonio M Gotto; Paul M Ridker; John J P Kastelein
Journal:  JAMA       Date:  2012-03-28       Impact factor: 56.272

6.  Reference levels of blood mercury and association with metabolic syndrome in Korean adults.

Authors:  Sang-Yong Eom; Sun-Hee Choi; Su-Ju Ahn; Dong-Kyeong Kim; Dong-Won Kim; Ji-Ae Lim; Byung-Sun Choi; Hye-Jung Shin; Sin-Weon Yun; Hae-Jung Yoon; Yu-Mi Kim; Young-Seoub Hong; Yong-Woon Yun; Seok-Joon Sohn; Heon Kim; Kyung-Su Park; Hee-Soo Pyo; Ho Kim; Se-Young Oh; Jeongseon Kim; Sang-Ah Lee; Mina Ha; Ho-Jang Kwon; Jung-Duck Park
Journal:  Int Arch Occup Environ Health       Date:  2013-07-04       Impact factor: 3.015

7.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

Authors:  B J Van Lenten; S Y Hama; F C de Beer; D M Stafforini; T M McIntyre; S M Prescott; B N La Du; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

8.  Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein.

Authors:  D J Lamb; D S Leake
Journal:  FEBS Lett       Date:  1994-01-31       Impact factor: 4.124

9.  Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.

Authors:  John K Ninomiya; Gilbert L'Italien; Michael H Criqui; Joanna L Whyte; Anthony Gamst; Roland S Chen
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

10.  Does dietary arsenic and mercury affect cutaneous bleeding time and blood lipids in humans?

Authors:  H M Meltzer; H H Mundal; J Alexander; K Bibow; T A Ydersbond
Journal:  Biol Trace Elem Res       Date:  1994 Oct-Nov       Impact factor: 3.738

View more
  1 in total

1.  Positive correlation of serum HDL cholesterol with blood mercury concentration in metabolic syndrome Korean men (analysis of KNANES 2008-2010, 2013).

Authors:  S M J Mortazavi; G Mortazavi; M Paknahad
Journal:  J Endocrinol Invest       Date:  2016-05-13       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.